Term
Clavulanic Acid
Molecular Target |
|
Definition
|
|
Term
|
Definition
|
|
Term
Clavulanic Acid
Disease/Symptoms |
|
Definition
| Anti-Bacterial agent used in combination with penicillin overcoming drug resistance |
|
|
Term
Muscarine
Molecular Target |
|
Definition
|
|
Term
|
Definition
|
|
Term
Muscarine
Disease/Symptom |
|
Definition
|
|
Term
Atropine
Molecular Target |
|
Definition
|
|
Term
|
Definition
|
|
Term
Atropine
Disease/Symptoms |
|
Definition
| Used to treat organophosphate poisoning, and resuscitation |
|
|
Term
Neostigmine
Molecular Target |
|
Definition
|
|
Term
|
Definition
|
|
Term
Neostigmine
Disease/Symptoms |
|
Definition
| Used to treat myasthenia gravis (an autoimmune disease) |
|
|
Term
Nerve Gase Agents: Sarin, Tabun, DFP, and VX
Molecular Target |
|
Definition
|
|
Term
Nerve Gase Agents: Sarin, Tabun, DFP, and VX
Molecular Target |
|
Definition
|
|
Term
Nerve Gase Agents: Sarin, Tabun, DFP, and VX
MOA |
|
Definition
|
|
Term
Nerve Gase Agents: Sarin, Tabun, DFP, and VX
Disease/Symptoms |
|
Definition
| None but are used in war as chemical war agents and by terrorists |
|
|
Term
Pralidoxime
Molecular Target |
|
Definition
|
|
Term
|
Definition
| Antidote used to remove irreversible organophosphate inhibitors from AChE |
|
|
Term
Pralidoxime
Disease/symptoms |
|
Definition
| Organophosphate poisoning |
|
|
Term
Pyridostigmine
Molecular Target |
|
Definition
|
|
Term
|
Definition
| Prophylactical to block or prevent organophosphate poisoning |
|
|
Term
Pyridostigmine
Disease/Symptoms |
|
Definition
| Used to prevent organophosphate poisoning but has been linked to Gulf War Syndrome |
|
|
Term
Imatinib (Gleevac)
Molecular Target |
|
Definition
|
|
Term
|
Definition
| Competitive BCR-ABL Inhibitor |
|
|
Term
Imatinib (Gleevac)
Disease/Symptoms |
|
Definition
| Used to treat various types of cancer but mainly Leukemia including: ALL, CEL, CML |
|
|
Term
Dasatinib (Sprycel)
Molecular Target |
|
Definition
|
|
Term
|
Definition
| Binds to the active form of ABL |
|
|
Term
Dasatinib (Sprycel)
Disease/Symptoms |
|
Definition
| Used to treat Imatinib resistant Leukemia that is Philadelphia chromosome positive |
|
|
